In Oregon, Compound Laws tracks 19 compounds: 5 legal to sell at retail, 5 restricted, 0 in a gray area, 4 illegal, and 5 whose status varies by product form. Verified through October 22, 2026.
c8c5b9075063a91c(a) Harvested industrial hemp or a hemp item must be tested by a laboratory using a method with a LOQ capable of detecting whether a sample exceeds any applicable concentration, serving size, or container limit separately for delta-9-THC and for the total THC equivalent of delta-9-THCA. (b) Harvested industrial hemp may not exceed a concentration of one percent total THC. (c) A hemp item other than a hemp concentrate or extract as defined in OAR 603-048-2310 (Definitions) may not exceed a concentration of one percent total THC. (d) A hemp concentrate or extract as defined in OAR 603-048-2310 (Definitions) may not exceed a concentration of five percent total THC. (e) A hemp item other than usable hemp or a hemp concentrate, extract, or tincture may not exceed 10 milligrams total THC in a container. A hemp concentrate, extract, or tincture may not exceed 50 milligrams total THC in a container. (f) A hemp item other than a hemp tincture that is intended for human consumption may not exceed one milligram total THC per serving.
54c935cb7a7ded6b[OLCC Hemp Registry FAQ:] "Hemp items must be registered with the OLCC if:" [sold to an Oregon consumer, intended for human or animal consumption or use, and not exclusively topical]. "On and after January 1, 2026, hemp items must be registered with OLCC and labeled in accordance with OLCC labeling rules" [...]. "Adult use cannabis items can only be sold to persons 21 and older." "The registration fee is $400". [Hemp Testing and Potency Guide: usable hemp, Oregon general market, 0.3% total THC (OAR 845-026-0400, -0410); minors-eligible products under 0.5 mg total THC (OAR 845-026-0300).] [Bracketed spans summarized.]
fb8e47873153c6de**OAR 855-080-0021(1)–(2) (federal incorporation + structural classes)** — "Schedule I consists of the drugs and other substances … listed in 21CFR part 1308.11, and unless specifically excepted or unless listed in another schedule, any quantity of the following substances …" then "Schedule I also includes any compounds in the following structural classes …" (cannabinoids/cathinones/fentanyls/benzodiazepines only).
— OAR 855-080-0021, https://oregon.public.law/rules/oar_855-080-0021 (MIRROR: public.law). No tryptamine structural class; 4-HO-MET not named.
**ORS 475.752(1) (prohibited acts — no analog reach)** — "it is unlawful for any person to manufacture or deliver a controlled substance. Any person who violates this subsection with respect to: (a) A controlled substance in Schedule I, is guilty of a Class A felony …" — the section reaches only "controlled substance" and (subsection (2)) "counterfeit substance." There is **no** "controlled substance analog" offense.
— ORS 475.752, https://oregon.public.law/statutes/ors_475.752 (MIRROR: public.law; sources to oregonlegislature.gov). ORS 475.005 (definitions) contains no "controlled substance analog" definition; the only related offense is ORS 475.912 ("Unlawful delivery of imitation controlled substance").b00bb0868fdfca45RULE TITLE: Schedule I NOTICE FILED DATE: 04/21/2020 RULE SUMMARY: Schedule I controlled substances in Oregon RULE TEXT: (1) Schedule I consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in 21CFR part 1308.11, and unless specifically excepted or unless listed in another schedule, any quantity of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (a) 1,4-butanediol; (b) Gamma-butyrolactone (c) Methamphetamine, except as listed in OAR 855-080-0022; (d) Dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide (U-47700) (e) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene]benzenesulfonamide (W-18) and positional isomers thereof, and any substituted derivative of W-18 and its positional isomers, and their salts, by any substitution on the piperidine ring (including replacement of all or part of the nitrophenylethyl group), any substitution on or replacement of the sulfonamide, or any combination of the above that are not FDA approved drugs, unless specifically excepted or when in the possession of an FDA registered manufacturer or a registered research facility, or a person for the purpose of sale to an FDA registered manufacturer or a registered research facility. (f) Substituted derivatives of cathinone and methcathinone that are not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or are not FDA approved drugs, including but not limited to, (A) Methylmethcathinone (Mephedrone); (B) Methylenedioxypyrovalerone (MDPV); (C) Methylenedioxymethylcathinone (Methylone); (D) 2-Methylamino-3’,4’-(methylenedioxy)-butyrophenone (Butylone); (E) Fluoromethcathinone (Flephedrone); (F) 4-Methoxymethcathinone (Methedrone). (2) Schedule I also includes any compounds in the following structural classes (2a–2k) and their salts, that are not FDA approved drugs, unless specifically excepted or when in the possession of an FDA registered manufacturer or a registered research facility, or a person for the purpose of sale to an FDA registered manufacturer or a registered research facility: (a) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Examples of this structural class include but are not limited to: JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, AM-1220, MAM-2201 and AM-2201; (b) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Examples of this structural class include but are not limited to: JWH-167, JWH -201, JWH-203, JWH-250, JWH-251, JWH-302 and RCS-8; (c) Benzoylindoles: Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Examples of this structural class include but are not limited to: RCS-4, AM-694, AM-1241, and AM-2233; (d) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5- position of the phenolic ring whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural Page 2 of 4 class include but are not limited to: CP 47,497 and its C8 homologue (cannabicyclohexanol); (e) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (f) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (g) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl) indene structure with substitution at the 3-position of the indene ring whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent; (h) Cyclopropanoylindoles: Any compound containing an 3-(cyclopropylmethanoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent and whether or not substituted in the cyclopropyl ring to any extent. Examples of this structural class include but are not limited to: UR- 144, XLR-11 and A-796,260; (i) Adamantoylindoles: Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples of this structural class include but are not limited to: AM- 1248 and AB-001; (j) Adamantylindolecarboxamides: Any compound containing an N-adamantyl-1-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples of this structural class include but are not limited to: STS-135 and 2NE1; and (k) Adamantylindazolecarboxamides: Any compound containing an N-adamantyl-1-indazole-3-carboxamide with substitution at the nitrogen atom of the indazole ring, whether or not further substituted in the indazole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples of this structural class include but are not limited to: AKB48. (3) Schedule I also includes any other cannabinoid receptor agonist that is not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or is not an FDA approved drug. (4) Schedule I also includes any substituted derivatives of fentanyl that are not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or are not FDA approved drugs, and are derived from fentanyl by any substitution on or replacement of the phenethyl group, any substitution on the piperidine ring, any substitution on or replacement of the propanamide group, any substitution on the phenyl group, or any combination of the above. (5) Schedule I also includes any compounds in the following structural classes (a – b), and their salts, that are not listed in OARs 855-080-0022 through 0026 (Schedules II through V) or FDA approved drugs, unless specifically excepted or when in the possession of an FDA registered manufacturer or a registered research facility, or a person for the purpose of sale to an FDA registered manufacturer or a registered research facility: (a) Benzodiazepine class: A fused 1,4-diazepine and benzene ring structure with a phenyl connected to the diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine or benzene ring, any substitution(s) on the phenyl ring, or any combination thereof. Examples of this structural class include but are not limited to: Clonazolam, Flualprazolam (b) Thienodiazepine class: A fused 1,4-diazepine and thiophene ring structure with a phenyl connected to the 1,-4- diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine or thiophene ring, any substitution(s) on the phenyl ring, or any combination thereof. Examples of this structural class include but are not limited to: Etizolam (6) Exceptions. The following are exceptions to subsection (1) of this rule: (a) 1, 4-butanediol and gamma-butyrolactone when in the possession of a person for the purpose of its sale to a legitimate manufacturer of industrial products and the person is in compliance with the Drug Enforcement Administration requirements for List I Chemicals; Page 3 of 4 (b) 1, 4-butanediol and gamma-butyrolactone when in the possession of a person for the purpose of the legitimate manufacture of industrial products; (c) Marijuana and delta-9-tetrahydrocannabinol (THC).
e23ab3420a1c13e0In general, hemp-derived beverages that contain artificially derived cannabinoids are prohibited from being sold in Oregon. The only exception to this rule is if the artificially derived cannabinoid has been approved for sale by the OLCC. Cannabinoids that are sometimes manufactured as artificially derived cannabinoids include delta-9-THC, delta-8-THC, CBN, HHC, and THCO. However, some of these cannabinoids (e.g. delta-9-THC, CBN) can also occur naturally in hemp. Whether a product containing these cannabinoids is eligible for sale to Oregon consumers depends on how the cannabinoids were made.
b842f61aab77ff9bORS 431A.175(1)(b) "Inhalant delivery system" means: A device that can be used to deliver nicotine or cannabinoids in the form of a vapor or aerosol to a person inhaling from the device; or a component of a device described in this subparagraph or a substance in any form sold for the purpose of being vaporized or aerosolized by a device described in this subparagraph, whether the component or substance is sold separately or is not sold separately. [Excludes FDA-approved cessation products and traditional tobacco products.] (2) It is unlawful: (a) To violate ORS 167.755. [Remaining paragraphs summarized by fetch tool: failing to post notice that sale to persons under 21 is prohibited; distributing systems without labeling required by authority rules; without child-resistant packaging; or in packaging attractive to minors.] History: formerly 431.840; 2017 c.701 s.10; 2019 c.525 s.16. OAR 845-026-0300 (Justia fallback): an industrial hemp product is an adult use cannabis item if it contains "0.5 milligrams or more of: Total delta-9-THC; Any other tetrahydrocannabinol or tetrahydrocannabinolic acid, including delta-8-tetrahydrocannabinol; or Any other cannabinoids advertised by the manufacturer or seller as having an intoxicating effect"; or "any quantity of artificially derived cannabinoids"; or if "the testing done in accordance with ORS 571.330 or 571.339 was performed using a method with a LOQ that is not sufficient to demonstrate that the total delta-9-THC does not exceed 0.5 milligrams." "The Commission may impose a civil penalty of no more than $10,000 for each violation." (Bracketed text summarized by fetch tool.)
29fbf0d9026a2f33ORS 475.394 Definitions. (1) "Kratom product" means a food ... containing any part of the leaf of the plant Mitragyna speciosa. (2) "Processor" ... wholesale to a retailer. (3) "Retailer" ... to individuals for personal consumption. [2022 c.41 s2] ORS 475.396 (1) A processor may not sell, distribute or expose for sale a kratom product prior to registering with the Department of Revenue under ORS 475.404. (2) civil penalty up to $500 first / $1,000 subsequent. [2022 c.41 s3] ORS 475.398 (1) A retailer may not sell, distribute or expose for sale a kratom product to an individual under 21 years of age. (2) Class C misdemeanor for each violation. [2022 c.41 s4] Implementing rules OAR 150-475-6010 (annual DOR registration, $460 fee) and OAR 150-475-6020 (third-party testing of >=0.5% by volume of each batch for microbiological/pesticide/solvent/heavy-metal/mycotoxin CONTAMINANTS only - NO potency/7-OH limit). REV 10-2023, eff. 6/1/2023.
c48937457ccd8b69As used in ORS 475C.005 (Short title) to 475C.525 (Severability of ORS 475C.005 to 475C.525): (1) "Adult use cannabinoid" includes, but is not limited to, tetrahydrocannabinols, tetrahydrocannabinolic acids that are artificially or naturally derived, delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, the optical isomers of delta-8-tetrahydrocannabinol or delta-9-tetrahydrocannabinol and any artificially derived cannabinoid that is reasonably determined to have an intoxicating effect. (2) "Adult use cannabis item" means: (a) A marijuana item; or (b) An industrial hemp commodity or product that exceeds: (A) The concentration of adult use cannabinoids established by the Oregon Liquor and Cannabis Commission, in consultation with the Oregon Health Authority and the State Department of Agriculture, by rule; or (B) The greater of: (i) A concentration of more than 0.3 percent total delta-9-tetrahydrocannabinol; or (ii) The concentration of total delta-9-tetrahydrocannabinol allowed under federal law. (3)(a) "Artificially derived cannabinoid" means a chemical substance that is created by a chemical reaction that changes the molecular structure of any chemical substance derived from the plant Cannabis family Cannabaceae. (b) "Artificially derived cannabinoid" does not include: (A) A naturally occurring chemical substance that is separated from the plant Cannabis family Cannabaceae by a chemical or mechanical extraction process; (B) Cannabinoids that are produced by decarboxylation from a naturally occurring cannabinoid acid without the use of a chemical catalyst; or (C) Any other chemical substance identified by the commission, in consultation with the authority and the department, by rule. (42) "Total delta-9-tetrahydrocannabinol" or "total delta-9-THC" means the sum of the concentration or mass of delta-9-THCA multiplied by 0.877 plus the concentration or mass of delta-9-THC.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap